References
1. Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters
and biofilms: where do we stand in 2017? APMIS .
2017;125(4):365-375. doi:10.1111/apm.12665
2. Cabrini L, Pappacena S, Mattioli L, et al. Administration of blood
products to prevent bleeding complications associated with central
venous catheter insertion in patients at risk: a systematic review.Br J Anaesth . 2017;118(4):630-634. doi:10.1093/bja/aex060
3. Estcourt LJ, Desborough M, Hopewell S, Doree C, Stanworth SJ.
Comparison of different platelet transfusion thresholds prior to
insertion of central lines in patients with thrombocytopenia. Cochrane
Haematological Malignancies Group, ed. Cochrane Database Syst
Rev . Published online December 2, 2015.
doi:10.1002/14651858.CD011771.pub2
4. Study collaborative, van de Weerdt EK, Biemond BJ, et al.
Prophylactic platelet transfusion prior to central venous catheter
placement in patients with thrombocytopenia: study protocol for a
randomised controlled trial. Trials . 2018;19(1):127.
doi:10.1186/s13063-018-2480-3
5. Agarwal RK, Sedai A, Dhimal S, et al. A prospective international
cooperative information technology platform built using open-source
tools for improving the access to and safety of bone marrow
transplantation in low- and middle-income countries. J Am Med
Inform Assoc . 2014;21(6):1125-1128. doi:10.1136/amiajnl-2013-002594
6. Sandeep, Priya G, Prasad S, et al. Patterns of central line
infections in two bone marrow transplant units in India among children
undergoing allogeneic transplant for thalassaemia. Pediatr Hematol
Oncol J . 2018;3(3):S56. doi:10.1016/j.phoj.2018.11.161
7. Stecker MS, Johnson MS, Ying J, et al. Time to Hemostasis after
Traction Removal of Tunneled Cuffed Central Venous Catheters. J
Vasc Interv Radiol . 2007;18(10):1232-1239.
doi:10.1016/j.jvir.2007.06.035
8. Rodriguez D, Park BJ, Almirante B, et al. Impact of early central
venous catheter removal on outcome in patients with candidaemia.Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis .
2007;13(8):788-793. doi:10.1111/j.1469-0691.2007.01758.x
9. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the
Prevention of Intravascular Catheter-related Infections. Clin
Infect Dis . 2011;52(9):e162-e193. doi:10.1093/cid/cir257
10. Gahlot R, Nigam C, Kumar V, Yadav G, Anupurba S. Catheter-related
bloodstream infections. Int J Crit Illn Inj Sci .
2014;4(2):162-167. doi:10.4103/2229-5151.134184
11. Soufir L, Timsit J-F, Mahe C, Carlet J, Regnier B, Chevret S.
Attributable Morbidity and Mortality of Catheter-Related Septicemia in
Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study.Infect Control Hosp Epidemiol . 1999;20(6):396-401.
doi:10.1086/501639
12. Lebeaux D, Chauhan A, Létoffé S, et al. pH-mediated potentiation of
aminoglycosides kills bacterial persisters and eradicates in vivo
biofilms. J Infect Dis . 2014;210(9):1357-1366.
doi:10.1093/infdis/jiu286
13. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for
infection of adult patients with cancer who have tunnelled central
venous catheters. Cancer . 1995;75(6):1367-1375.
doi:10.1002/1097-0142(19950315)75:6<1367::aid-cncr2820750620>3.0.co;2-z
14. Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The Global
Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A
Perspective From Asia. Weinstein RA, ed. Clin Infect Dis .
2013;56(9):1310-1318. doi:10.1093/cid/cit020